Literature DB >> 14716559

Ethical principles and operational guidelines for good clinical practice in paediatric research. Recommendations of the Ethics Working Group of the Confederation of European Specialists in Paediatrics (CESP).

Denis Gill1.   

Abstract

A child has the full right of protection of his/her life by provision of optional medical care. There is a need in paediatrics for better evidence based practice founded on quality research into efficacy and safety of children's medications. To protect the best interests of the child one must balance the ethical demand to do clinical studies with the necessity to avoid doing harm. To achieve this end good clinical practice in paediatric research demands that studies comply with the Declaration of Helsinki, ICH topic E11, EU Directives and other relevant international guidelines. Evident differences in physiology, pharmacology, pharmacokinetics and pharmacodynamics between children of differing ages and between children and adults demand properly constructed and conducted studies that respect the special somatic, emotional and mental needs of children. To justify any research project one must balance the benefit/risk ratio, provide experienced, competent personnel and infracture, obtain adequate informed consent/assent, and have the study evaluated and approved by an ethics committee containing expertise on the rights and needs of children.

Entities:  

Mesh:

Year:  2004        PMID: 14716559     DOI: 10.1007/s00431-003-1378-5

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  7 in total

1.  Ethical overview of paediatric research and practice in Europe from the Ethical Working Group of the Confederation of European Specialists in Paediatrics (CESP).

Authors:  T L Chambers; R Kurz
Journal:  Eur J Pediatr       Date:  1999-07       Impact factor: 3.183

2.  Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the member states relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use.

Authors: 
Journal:  Med Etika Bioet       Date:  2002 Spring-Summer

Review 3.  Research in children. A report of the Ethics Working Group of the CESP.

Authors:  Pieter J J Sauer
Journal:  Eur J Pediatr       Date:  2002-01       Impact factor: 3.183

4.  Guidelines for the ethical conduct of medical research involving children. Royal College of Paediatrics, Child Health: Ethics Advisory Committee.

Authors:  N McIntosh; P Bates; G Brykczynska; G Dunstan; A Goldman; D Harvey; V Larcher; D McCrae; A McKinnon; M Patton; J Saunders; P Shelley
Journal:  Arch Dis Child       Date:  2000-02       Impact factor: 3.791

5.  Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children.

Authors:  S Conroy; I Choonara; P Impicciatore; A Mohn; H Arnell; A Rane; C Knoeppel; H Seyberth; C Pandolfini; M P Raffaelli; F Rocchi; M Bonati; G Jong; M de Hoog; J van den Anker
Journal:  BMJ       Date:  2000-01-08

6.  Guidelines for informed consent in biomedical research involving paediatric populations as research participants.

Authors:  Dennis Gill
Journal:  Eur J Pediatr       Date:  2003-04-26       Impact factor: 3.183

7.  Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study.

Authors:  S Turner; A J Nunn; K Fielding; I Choonara
Journal:  Acta Paediatr       Date:  1999-09       Impact factor: 2.299

  7 in total
  31 in total

1.  Ethical challenges in paediatric clinical trials in multiple sclerosis.

Authors:  Silvia N Tenembaum
Journal:  Ther Adv Neurol Disord       Date:  2012-05       Impact factor: 6.570

2.  Informing children and parents about research.

Authors:  A Dawson; S A Spencer
Journal:  Arch Dis Child       Date:  2005-03       Impact factor: 3.791

3.  A questionnaire on factors influencing children's assent and dissent to non-therapeutic research.

Authors:  O D Wolthers
Journal:  J Med Ethics       Date:  2006-05       Impact factor: 2.903

4.  Consequences of Directive 2001/20/EC for investigator-initiated trials in the paediatric population--a field report.

Authors:  Lars Welzing; Urs Harnischmacher; Annic Weyersberg; Bernhard Roth
Journal:  Eur J Pediatr       Date:  2007-02-27       Impact factor: 3.183

5.  Paediatric clinical pharmacology: at the beginning of a new era.

Authors:  Kalle Hoppu
Journal:  Eur J Clin Pharmacol       Date:  2007-10-31       Impact factor: 2.953

6.  Regulating trust in pediatric clinical trials.

Authors:  Wim Pinxten; Herman Nys; Kris Dierickx
Journal:  Med Health Care Philos       Date:  2008-07-18

Review 7.  Population clinical pharmacology of children: general principles.

Authors:  Brian J Anderson; Karel Allegaert; Nicholas H G Holford
Journal:  Eur J Pediatr       Date:  2006-06-29       Impact factor: 3.183

8.  Ethical assessment of pediatric research protocols.

Authors:  Robert D Truog
Journal:  Intensive Care Med       Date:  2007-11-03       Impact factor: 17.440

9.  No child left behind: Enrolling children and adults simultaneously in critical care randomized trials.

Authors:  Scott D Halpern; Adrienne G Randolph; Derek C Angus
Journal:  Crit Care Med       Date:  2009-09       Impact factor: 7.598

10.  A time-to-event model for acute rejections in paediatric renal transplant recipients treated with ciclosporin A.

Authors:  Anne-Kristina Frobel; Mats O Karlsson; Janne T Backman; Kalle Hoppu; Erik Qvist; Paula Seikku; Hannu Jalanko; Christer Holmberg; Ron J Keizer; Samuel Fanta; Siv Jönsson
Journal:  Br J Clin Pharmacol       Date:  2013-10       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.